Agriculture Reference
In-Depth Information
Appropriateness . Will it be affordable, robust, and adjustable to health care
settings in developing countries, and will it be socially, culturally, and
politically acceptable?
Burden . Will it address the most pressing health needs?
Feasibility . Can it be developed realistically and deployed in a time frame
of 5 to 10 years?
Knowledge gap . Does the technology advance health by creating new
knowledge?
Indirect benefits . Does it address issues such as environmental improvement
and income generation that have indirect, positive effects on health?
Table B5.1 Ranking by Global Health Experts of the Top Ten Biotechnologies Needed to
Improve Health in Developing Countries
Final
Ranking
Biotechnology
1
Modified molecular technologies for simple, affordable
diagnosis of infectious diseases
2
Recombinant technologies to develop vaccines against
infectious diseases
3
Technologies for more efficient drug and vaccine delivery
systems
4
Technologies for environmental improvement (sanitation,
clean water, bioremediation)
5
Sequencing pathogen genomes to understand their biology
and to identify new antimicrobials
6
Female-controlled protection against sexually transmitted
diseases, both with and without contraceptive effect
7
Bioinformatics to identify drug targets and to examine
pathogen-host interactions
8
Genetically modified crops with increased nutrients to
counter specific deficiencies
9
Recombinant technology to make therapeutic products (e.g.,
insulin, interferons) more affordable
10
Combinatorial chemistry for drug discovery
Source: Data from a survey rported by A. S. Daar, H. Thorsteinsdottir, D. K. Martin, A. C. Smith,
S. Nast, and P. A. Singer, “Top ten biotechnologies for improving health in developing countries,”
Nature Genetics , 32, 229-232, 2002.
 
Search WWH ::




Custom Search